This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
Yesterday’s UK 100 Leaders | Price (p) | % Chg |
Rolls-Royce Holdings PLC | 214.2 | 6.0% |
Croda International PLC | 4,397.0 | 3.1% |
Kingfisher PLC | 209.8 | 2.7% |
Segro PLC | 711.4 | 2.6% |
Smurfit Kappa Group PLC | 2,698.0 | 2.2% |
Yesterday’s UK 100 Laggards | Price (p) | % Chg |
BP PLC | 502.8 | -4.5% |
Glencore PLC | 432.1 | -4.2% |
Intercontinental Hotels Group PLC | 5,804.0 | -3.1% |
Antofagasta PLC | 1,341.0 | -2.1% |
Shell PLC | 2,638.5 | -1.8% |
Major World Indices | Price | % Chg | 1 YEAR |
UK 100 INDEX | 7,319 | -0.1% | 3.8% |
DOW JONES INDUS. AVG | 32,922 | 0.0% | 0.5% |
DAX INDEX | 14,791 | 0.5% | 11.5% |
NIKKEI 225 | 30,859 | 0.5% | 11.5% |
S&P/ASX 200 INDEX | 6,781 | 0.1% | -2.8% |
Commodities | Units | Price | % Chg |
WTI Crude Oil (Nymex) | USD/bbl. | 82.79 | 0.58% |
Brent Crude (ICE) | USD/bbl. | 87.87 | 0.48% |
Gold Spot | USD/t oz. | 1,990 | -0.3% |
Copper (Comex) | USd/lb. | 365 | -0.2% |
The UK 100 called to open +31 points at 7,352. The UK 100 is expected to open higher on Wednesday after US markets reversed early falls to close ahead of today’s interest rate decision by the US Federal Reserve. In the US on Tuesday, the Dow Jones Industrial Average rose 0.4%, the S&P 500 rose 0.7% and the Nasdaq Composite rose 0.5%. In Asia, Chinese manufacturing returned to a mild state of contraction in October, survey data revealed. The Caixin manufacturing purchasing managers’ index fell to 49.5 points in the month from 50.6 in September.
ASOS expects their sales to decline by 5-15% in FY24, as they report a FY23 pretax loss of £296.7m, up from a loss of £31.9m YoY.
Aston Martin Lagonda have lowered their 2023 volume outlook due to production issues for their DB12, after reporting a small Q3 loss. They retained the rest of their 2023 outlook, but reported an adjusted Q3 operating loss of £48.4m on revenue of £362.1m. Analysts had expected an adjusted operating loss of £38m on revenue of £370m.
GSK have raised their FY profit and sales forecast for the second time this year, betting on the strong launch of its respiratory syncytial virus vaccine (RSV) and steady demand for its shingles shot. Analysts expect GSK’s RSV vaccine Arexvy to power future growth and is expected to garner FY sales of between £900m-£1bn. They now also expect a rise of 17%-20% in their adjusted earnings per share, up from 14%-17% growth previously forecast.
John Wood appoints Arvind Balan as CFO effective from 15th April.
Next have raised their FY profit outlook for the fourth time in six months as they reported a better-than-expected 4% rise in their Q3 full-price sales.
Weir Group says their Q3 performance has met expectations, with revenue and operating margins up YoY. They have also appointed Brian Puffer as their CFO, who will join on 1st April.
Goldman Sachs Downgrades Segro to Sell (6 Buys / 6 Holds / 0 Sells)
JP Morgan Downgrades BP to Underweight from Neutral (6 Buys / 7 Holds / 0 Sells)
UK
Aston Martin Lagonda Global Holdings
GSK
Next
Smurfit Kappa Group
US
The Estee Lauder Companies
The Kraft Heinz Co
Etsy
Lemonade
Liberty Global
MicroStrategy
Mondelez
PayPal Holdings
Qualcomm Inc
Roku Inc
Airbnb
UK
BT Group
Haleon
Helios Towers
Howden Joinery Group
OSB Group
Sainsbury (J)
Shell
Smith & Nephew
TI Fluid Systems
Trainline
US
Ball Corp
Barrick Gold
Eli Lilly and Co
Moderna
Novo Nordisk
Palantir Technologies
Starbucks Corp
Apple Inc
Block
Coinbase Global
Shopify
Virgin Galactic
Caixin Manufacturing PMI
US ADP Employment Change
US ISM Manufacturing PMI
US JOLTS Job Openings
Fed Interest Rate Decision
Fed Monetary Policy Statement
FOMC Press Conference
UK 100 companies going ex-dividend on 2nd November 2023:
Whitbread
UK 250 companies going ex-dividend on 2nd November 2023:
Ashmore Group
PZ Cussons
European Smaller Companies Trust
ME Group International
Renishaw
Hilton Food Group
Tritax Big Box REIT
BlackRock Smaller Companies Trust
VinaCapital Vietnam Opportunity Fund
Edinburgh Investment Trust
European Opportunities Trust
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.